Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical In Vivo Models: Identification of Targets and New Modalities for Therapeutic Intervention
Cancer Genomics - Proteomics · 2024
DOI: 10.21873/cgp.20442 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Genomics - Proteomics, 2024. Verfasst von Ulrich H Weidle und 1 weiteren Autor:innen. Beteiligte Einrichtung: Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany; weidle49@t-online.de. Hauptthemen laut MEDLINE: RNA, Circular, Carcinoma, Ovarian Epithelial, Ovarian Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany; weidle49@t-online.de.
- Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland fabian.birzele@roche.com.
Zitieren
APA
Weidle, U. H., & Birzele, F. (2024). Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical In Vivo Models: Identification of Targets and New Modalities for Therapeutic Intervention. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20442
Vancouver
Weidle UH, Birzele F. Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical In Vivo Models: Identification of Targets and New Modalities for Therapeutic Intervention. Cancer Genomics - Proteomics. 2024. doi:10.21873/cgp.20442
BibTeX
@article{Weidle2024,
author = {Weidle, Ulrich H and Birzele, Fabian},
title = {Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical In Vivo Models: Identification of Targets and New Modalities for Therapeutic Intervention},
journal = {Cancer Genomics - Proteomics},
year = {2024},
doi = {10.21873/cgp.20442}
}
EUVIMED